Table 2.
Geometric means | ||||
---|---|---|---|---|
Urinary biomarkersa | Placebo | PEITC | % Difference (95% CI) | P-valueb |
MHBMA (ng/mg Cr) | 11.0 | 12.3 | 11.13 (−4.2, 28.9) | 0.17 |
DHBMA (ng/mg Cr) | 572.9 | 593.8 | 3.7 (−10.9, 20.6) | 0.64 |
Urinary biomarkers were adjusted for creatinine and batch, and log-transformed.
Two-sided p-values were from mixed models that test the PEITC treatment effect, after adjusting for creatinine-adjusted TNE